Apport de l’immunologie au diagnostic en néphrologie : actualités en 2012

Madaio, 1983, Current concepts. The diagnosis of acute glomerulonephritis, N Engl J Med, 309, 1299, 10.1056/NEJM198311243092106 Beauvillain, 2012, Autoanticorpsanti-cytoplasme des polynucléaires neutrophiles (ANCA) : cibles antigéniques, méthodes diagnostiques, EMC Biologie médicale, 7, 1 Beauvillain, 2012, ANCA et vascularites : diagnostic et physiopathologie, EMC Biologie médicale, 7, 1 Doria, 2010, SLE diagnosis and treatment : when early is early, Autoimmun Rev, 10, 55, 10.1016/j.autrev.2010.08.014 Kallenberg, 2008, Anti-C1q autoantibodies, Autoimmun Rev, 7, 612, 10.1016/j.autrev.2008.06.006 Ahearn, 2012, Biomarkers for systemic lupus erythematosus, Transl Res, 159, 326, 10.1016/j.trsl.2012.01.021 Beauvillain, 2011, Immunoglobulines monoclonales : méthodes diagnostiques en 2011, Rev Fr Lab, 435, 55 Basnayake, 2011, The biology of immunoglobulin free light chains and kidney injury, Kidney Int, 79, 1289, 10.1038/ki.2011.94 Bridoux, 2012, Renal disorders associated with monoclonal gammopathies : diagnostic and therapeutic progress [Article in French], Presse Med, 41, 276, 10.1016/j.lpm.2011.11.008 Beauvillain, 2009, Apport des tests de quantification de la libération d’interféron gamma par les lymphocytes T sensibilisés pour le diagnostic des infections tuberculeuses, Rev Fr Lab, 410, 33 Hertig, 2010, Hemolytic uremic syndrome in adults [Article in French], Nephrol Ther, 6, 258, 10.1016/j.nephro.2010.03.002 Westra, 2012, À new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome, Neth J Med, 70, 121 Noris, 2009, Atypical hemolytic-uremic syndrome, N Engl J Med, 361, 1676, 10.1056/NEJMra0902814 Frémeaux-Bacchi, 2011, Atypical hemolytic-uremic syndrome related to abnormalities within the complement system [Article in French], Rev Med Int, 32, 232, 10.1016/j.revmed.2009.09.039 Gasser, 1955, Hemolytic-uremic syndrome : bilateral necrosis of the renal cortex in acute acquired hemolytic anemia, Schweiz Med Wochenschr, 85, 905 Kavanagh, 2011, Atypical hemolytic uremic syndrome, genetic basis, and clinical manifestations, Hematology Am Soc Hematol Educ Program, 2011, 15, 10.1182/asheducation-2011.1.15 Kavanagh, 2011, Haemolytic uraemic syndrome, Nephron Clin Pract, 118, c37, 10.1159/000320901 Boyer, 2011, Hemolytic uremic syndrome : new developments in pathogenesis and treatment, Int J Nephrol, 2011, 908407, 10.4061/2011/908407 Beutin, 2012, Outbreak of Shiga toxin-producing Escherichia coli (STEC) O104 :H4 infection in Germany causes a paradigm shift with regard to human pathogenicity of STEC strains, J Food Prot, 75, 408, 10.4315/0362-028X.JFP-11-452 Frank, 2011, Epidemic profile of Shiga-toxin-producing Escherichia coli O104 :H4 outbreak in Germany, N Engl J Med, 365, 1771, 10.1056/NEJMoa1106483 Liszewski, 2011, Too much of a good thing at the site of tissue injury : the instructive example of the complement system predisposing to thrombotic microangiopathy, Hematology Am Soc Hematol Educ Program, 2011, 9, 10.1182/asheducation-2011.1.9 Thompson, 1981, Hypocomplementaemia due to a genetic deficiency of beta 1H globulin, Clin Exp Immunol, 46, 110 Warwicker, 1998, Genetic studies into inherited and sporadic hemolytic uremic syndrome, Kidney Int, 53, 836, 10.1111/j.1523-1755.1998.00824.x Nilsson, 2011, Complement factor I in health and disease, Mol Immunol, 48, 1611, 10.1016/j.molimm.2011.04.004 Hodgkins, 2012, Clinical grand rounds : atypical hemolytic uremic syndrome, Am J Nephrol, 35, 394, 10.1159/000337954 Loirat, 2012, Management of hemolytic uremic syndrome, Presse Med, 41, e115, 10.1016/j.lpm.2011.11.013 Herrmann, 2012, Membranous nephropathy : the start of a paradigm shift, Curr Opin Nephrol Hypertens, 21, 203, 10.1097/MNH.0b013e32835026ed Callard, 2008, Glomérulonéphrites extra-membraneuses, 165 Fervenza, 2008, Idiopathic membranous nephropathy : diagnosis and treatment, Clin J Am Soc Nephrol, 3, 905, 10.2215/CJN.04321007 Beck, 2009, M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, 361, 11, 10.1056/NEJMoa0810457 Beck, 2010, Membranous nephropathy : recent travels and new roads ahead, Kidney Int, 77, 765, 10.1038/ki.2010.34 Jefferson, 2010, Experimental models of membranous nephropathy, Drug Discov Today Dis Models, 7, 27, 10.1016/j.ddmod.2010.11.001 Ronco, 2010, Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy, J Am Soc Nephrol, 21, 564, 10.1681/ASN.2009121220 Rees, 2009, Nephrotic syndrome : a watershed in the understanding of membranous nephropathy, Nat Rev Nephrol, 5, 617, 10.1038/nrneph.2009.167 Debiec, 2002, Antenatal membranous glomerulonephritis due to anti–neutral endopeptidase antibodies, N Engl J Med, 346, 2053, 10.1056/NEJMoa012895 Lees, 1998, Immunophénotypage des lymphocytes. Cluster de différenciation humains, 40 Hanasaki, 2004, Mammalian phospholipase A2 : phospholipase A2 receptor, Biol Pharm Bull, 27, 1165, 10.1248/bpb.27.1165 Liu, 2010, Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan, J Biomed Sci, 11, 17 Stanescu, 2011, Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, 364, 616, 10.1056/NEJMoa1009742 Hofstra, 2012, Anti-PLA 2R antibodies in membranous nephropathy : ready for routine clinical practice ?, Neth J Med, 70, 109 Beck, 2011, Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy, J Am Soc Nephrol, 22, 1543, 10.1681/ASN.2010111125 Stahl, 2010, PLA2R autoantibodies and recurrent membranous nephropathy after transplantation, N Engl J Med, 363, 496, 10.1056/NEJMc1003066 Hoxha, 2012, Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy, Kidney Int, 10.1038/ki.2012.209 Prunotto, 2010, Autoimmunity in membranous nephropathy targets aldose reductase and SOD2, J Am Soc Nephrol, 21, 507, 10.1681/ASN.2008121259 Bruschi, 2011, Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis : Alfa-enolase and borderline antigens, J Proteomics, 74, 2008, 10.1016/j.jprot.2011.05.021 Debiec, 2011, Early-childhood membranous nephropathy due to cationic bovine serum albumin, N Engl J Med, 364, 2101, 10.1056/NEJMoa1013792 Hoxha, 2011, An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis, Nephrol Dial Transplant, 26, 2526, 10.1093/ndt/gfr247 Kanigicherla, 2011, Association of anti-PLA2R with disease activity and outcome in idiopathic membranous nephropathy [abstract], J Am Soc Nephrol, 22, 33A Stone, 2012, Ig G4-related disease, N Engl J Med, 366, 539, 10.1056/NEJMra1104650 Ferrari, 2009, Ig G subclass distribution of anti-ADAMS 13 antibodies in patients with acquired thrombotic thrombocytopenic purpura, J Thromb Haemost, 7, 1703, 10.1111/j.1538-7836.2009.03568.x Takako, 2010, Clinico pathological characteristics of patients with Ig G4-remated tubulointerstitial nephritis, Kidney Int, 78, 1016, 10.1038/ki.2010.271 Lynn, 2010, Ig G4-related tubulointerstitial nephritis, Kidney Int, 78, 951, 10.1038/ki.2010.342 Aucouturier, 1988, Serum levels of Ig G subclasses in the normal child. Evaluation by an immunoenzymatic method using monoclonal antibodies, Arch Fr Pediatr, 45, 255 Pickering, 2011, Complement and glomerular disease : new insights, Curr Opin Nephrol Hypertens, 20, 271, 10.1097/MNH.0b013e328345848b